Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Chemoradiotherapy in Stage IIB-III Esophageal Cancer
NCT02279134Phase 3
Key facts
- Status
- Unknown
- Start
- Oct 2014
- Primary completion
- Dec 2022
- Countries
- 1
- Modality
- DNA Intercalators/Alkylators
- Conditions
- esophageal cancer
01
Overview
Phase 3, randomised, open-label trial of paclitaxel, cisplatin and nedaplatin in esophageal cancer. Status: unknown.
02
Design
- Study design
- RandomizedOpen-label
03
Registry description
This phase III trial is studying how well the combination of chemoradiation or radiation works in resected locally advanced cancer of the esophagus or gastroesophageal junction.
Beyond the preview
Go deeper on NCT02279134.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02279134.